The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants
Clinical trial NCT05829551 · COMPLETED
Trial details
- NCT number
- NCT05829551
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-20
- Primary completion
- 2022-08-12
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.